Skip to main content
Top
Published in:

Open Access 05-11-2024 | Demyelinating Disease | Case Report

Osmotic demyelination syndrome: revisiting the diagnostic criteria through two fatal cases

Authors: Biancamaria Treves, Francesca Consalvo, Giuseppe Delogu, Donato Morena, Martina Padovano, Alessandro Santurro, Matteo Scopetti, Vittorio Fineschi

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Osmotic Demyelination Syndrome (ODS) encompasses Central Pontine Myelinolysis and Extrapontine Myelinolysis, both of which are serious neurological conditions linked to the overly rapid correction of hyponatremia. Despite growing evidence, the exact etiology of ODS remains incompletely understood. The present paper describes two case studies, aiming to provide a comprehensive overview of the pathological findings and clinical outcomes associated with ODS.

Case presentation

Case #1. A 74-year-old woman was admitted to the emergency department following a head trauma caused by a loss of consciousness. Initial laboratory tests revealed severe hyponatremia (sodium level of 101 mmol/L) and hypokalemia (potassium level of 2.9 mmol/L). The patient underwent corrective therapy with saline and potassium chloride. Despite the correction of electrolyte imbalances, the patient developed a hyperintense lesion in the median portion of the pons on T2-fluid-attenuated inversion recovery (FLAIR) MRI sequence 14 days post-treatment, consistent with ODS. The patient’s condition deteriorated, leading to irreversible coma and status epilepticus, culminating in death 32 days after admission. Case #2. An 81-year-old woman with a medical history of hypothyroidism, hypertension, major depression, and stage 3 chronic kidney disease presented with mild gait disturbances. Subsequent testing revealed severe hyponatremia (sodium level of 100 mmol/L). Following an initial clinical improvement due to sodium correction, the patient’s condition worsened, with symptoms progressing to confusion, lethargy, and eventually, ODS. Dermatological manifestations, including blistering lesions and facial edema, appeared as the condition advanced. The patient succumbed to irreversible coma 47 days after admission.

Conclusion

ODS traditionally carried a poor prognosis, with high mortality rates and diagnoses often made postmortem. However, recent advances in understanding the pathophysiology, along with improvements in diagnostic techniques such as MRI and intensive care treatments, have led to earlier identification, treatment, and recognition of milder forms of the syndrome. Despite these advancements, ODS remains a critical condition with significant risks, particularly following the rapid correction of severe hyponatremia.
Literature
1.
go back to reference Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72.CrossRefPubMed Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72.CrossRefPubMed
2.
go back to reference Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–70.CrossRefPubMed Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–70.CrossRefPubMed
3.
go back to reference Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3 Suppl 3):iii22–28.PubMedPubMedCentral Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 3 Suppl 3):iii22–28.PubMedPubMedCentral
4.
go back to reference Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13:691.CrossRefPubMed Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13:691.CrossRefPubMed
5.
go back to reference Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol. 2014;21:1443–50.CrossRefPubMed Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol. 2014;21:1443–50.CrossRefPubMed
6.
go back to reference Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry. 2011;82:326–31.CrossRefPubMed Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry. 2011;82:326–31.CrossRefPubMed
7.
go back to reference Lambeck J, Hieber M, Dreßing A, Niesen W-D. Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int. 2019;116:600–6.PubMed Lambeck J, Hieber M, Dreßing A, Niesen W-D. Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int. 2019;116:600–6.PubMed
8.
go back to reference de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord. 2013;19:709–16.CrossRefPubMed de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord. 2013;19:709–16.CrossRefPubMed
9.
go back to reference de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res. 2012;34:262–71.CrossRefPubMed de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res. 2012;34:262–71.CrossRefPubMed
10.
go back to reference Peters M, Van der Hoeven J, Hoedemaekers C. Risk factors for poor outcome in patients with osmotic demyelination syndrome. Crit Care. 2012;16(Suppl 1):P143.CrossRefPubMedCentral Peters M, Van der Hoeven J, Hoedemaekers C. Risk factors for poor outcome in patients with osmotic demyelination syndrome. Crit Care. 2012;16(Suppl 1):P143.CrossRefPubMedCentral
11.
go back to reference Shintani M, Yamashita M, Nakano A, Aotani D, Maeda K, Yamamoto T, et al. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. Diabetes Res Clin Pract. 2005;68:75–80.CrossRefPubMed Shintani M, Yamashita M, Nakano A, Aotani D, Maeda K, Yamamoto T, et al. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. Diabetes Res Clin Pract. 2005;68:75–80.CrossRefPubMed
12.
go back to reference Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol. 2004;182:809–16.CrossRefPubMed Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol. 2004;182:809–16.CrossRefPubMed
13.
go back to reference Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170:G1–47.CrossRefPubMed Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170:G1–47.CrossRefPubMed
14.
go back to reference Woodfine JD, van Walraven C. Criteria for hyponatremic overcorrection: systematic review and cohort study of emergently ill patients. J Gen Intern Med. 2020;35:315–21.CrossRefPubMed Woodfine JD, van Walraven C. Criteria for hyponatremic overcorrection: systematic review and cohort study of emergently ill patients. J Gen Intern Med. 2020;35:315–21.CrossRefPubMed
15.
go back to reference Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1–42.CrossRefPubMed Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1–42.CrossRefPubMed
16.
go back to reference Sterns RH, Hix JK, Silver S. Treating profound hyponatremia: a strategy for controlled correction. Am J Kidney Dis. 2010;56:774–9.CrossRefPubMed Sterns RH, Hix JK, Silver S. Treating profound hyponatremia: a strategy for controlled correction. Am J Kidney Dis. 2010;56:774–9.CrossRefPubMed
17.
go back to reference Hanna RM, Yang W-T, Lopez EA, Riad JN, Wilson J. The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients. Clin Kidney J. 2016;9:530–9.CrossRefPubMedPubMedCentral Hanna RM, Yang W-T, Lopez EA, Riad JN, Wilson J. The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients. Clin Kidney J. 2016;9:530–9.CrossRefPubMedPubMedCentral
18.
go back to reference Edelman IS, Leibman J, O’meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37:1236–56.CrossRefPubMedPubMedCentral Edelman IS, Leibman J, O’meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest. 1958;37:1236–56.CrossRefPubMedPubMedCentral
19.
go back to reference Overgaard-Steensen C, Larsson A, Bluhme H, Tønnesen E, Frøkiaer J, Ring T. Edelman’s equation is valid in acute hyponatremia in a porcine model: plasma sodium concentration is determined by external balances of water and cations. Am J Physiol Regul Integr Comp Physiol. 2010;298:R120–129.CrossRefPubMed Overgaard-Steensen C, Larsson A, Bluhme H, Tønnesen E, Frøkiaer J, Ring T. Edelman’s equation is valid in acute hyponatremia in a porcine model: plasma sodium concentration is determined by external balances of water and cations. Am J Physiol Regul Integr Comp Physiol. 2010;298:R120–129.CrossRefPubMed
20.
go back to reference Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, et al. Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest. 2018;41:3–19.CrossRefPubMed Sbardella E, Isidori AM, Arnaldi G, Arosio M, Barone C, Benso A, et al. Approach to hyponatremia according to the clinical setting: consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest. 2018;41:3–19.CrossRefPubMed
21.
go back to reference Bose P. Central pontine myelinolysis and the osmotic demyelination syndromes: an open and shut case? Acta Neurol Belg. 2021;121:849–58.CrossRefPubMed Bose P. Central pontine myelinolysis and the osmotic demyelination syndromes: an open and shut case? Acta Neurol Belg. 2021;121:849–58.CrossRefPubMed
22.
go back to reference Popescu BFG, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun. 2013;1:40.CrossRefPubMedPubMedCentral Popescu BFG, Bunyan RF, Guo Y, Parisi JE, Lennon VA, Lucchinetti CF. Evidence of aquaporin involvement in human central pontine myelinolysis. Acta Neuropathol Commun. 2013;1:40.CrossRefPubMedPubMedCentral
23.
go back to reference Kalampokini S, Artemiadis A, Zis P, Hadjihannas L, Parpas G, Kyrri A, et al. Osmotic demyelination syndrome improving after immune-modulating treatment: case report and literature review. Clin Neurol Neurosurg. 2021;208:106811.CrossRefPubMed Kalampokini S, Artemiadis A, Zis P, Hadjihannas L, Parpas G, Kyrri A, et al. Osmotic demyelination syndrome improving after immune-modulating treatment: case report and literature review. Clin Neurol Neurosurg. 2021;208:106811.CrossRefPubMed
24.
go back to reference Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci. 1996;142:134–9.CrossRefPubMed Newell KL, Kleinschmidt-DeMasters BK. Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci. 1996;142:134–9.CrossRefPubMed
25.
go back to reference Furtado C, Nayak S, Jadun C, Srivastava S, Hashim Z. Radiological appearance and imaging techniques in the diagnosis of advanced central pontine myelinolysis. Cureus. 2022;14:e30328.PubMedPubMedCentral Furtado C, Nayak S, Jadun C, Srivastava S, Hashim Z. Radiological appearance and imaging techniques in the diagnosis of advanced central pontine myelinolysis. Cureus. 2022;14:e30328.PubMedPubMedCentral
27.
go back to reference Menger H, Jörg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol. 1999;246:700–5.CrossRefPubMed Menger H, Jörg J. Outcome of central pontine and extrapontine myelinolysis (n = 44). J Neurol. 1999;246:700–5.CrossRefPubMed
30.
go back to reference Sharif MW, Singh A, Enabi J, Karkee R, Sanivarapu R. Delayed presentation of osmotic demyelination syndrome treated with plasmapheresis. Cureus. 2023;15:e47399. Sharif MW, Singh A, Enabi J, Karkee R, Sanivarapu R. Delayed presentation of osmotic demyelination syndrome treated with plasmapheresis. Cureus. 2023;15:e47399.
31.
go back to reference Turillazzi E, Karch SB, Neri M, Pomara C, Riezzo I, Fineschi V. Confocal laser scanning microscopy. Using new technology to answer old questions in forensic investigations. Int J Legal Med. 2008;122:173–7.CrossRefPubMed Turillazzi E, Karch SB, Neri M, Pomara C, Riezzo I, Fineschi V. Confocal laser scanning microscopy. Using new technology to answer old questions in forensic investigations. Int J Legal Med. 2008;122:173–7.CrossRefPubMed
Metadata
Title
Osmotic demyelination syndrome: revisiting the diagnostic criteria through two fatal cases
Authors
Biancamaria Treves
Francesca Consalvo
Giuseppe Delogu
Donato Morena
Martina Padovano
Alessandro Santurro
Matteo Scopetti
Vittorio Fineschi
Publication date
05-11-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03934-3

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Advances in Alzheimer's

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Learn more